STENTiT Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 11

STENTiT General Information

Description

Developer of bioresorbable vascular implants designed to reconstruct arteries and restore blood flow through natural tissue regeneration. The company offers resorbable fibrillated scaffold technology, temporary arterial support, cell infiltration mechanisms, tissue reconstruction capabilities, and gradual implant resorption, enabling cardiovascular patients and healthcare providers to achieve improved vascular restoration outcomes.

Contact Information

Website
www.stentit.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • High Tech Campus 10
  • 5656 AE Eindhoven
  • Netherlands
+31 040
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • High Tech Campus 10
  • 5656 AE Eindhoven
  • Netherlands
+31 040

STENTiT Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

STENTiT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Accelerator/Incubator 18-Apr-2025 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Later Stage VC 17-Jul-2024 Completed Generating Revenue
6. Grant 02-Mar-2023 Completed Generating Revenue
5. Seed Round 15-Apr-2022 Completed Generating Revenue
4. Grant 15-Aug-2019 Completed Generating Revenue
3. Grant 06-Jun-2019 Completed Generating Revenue
2. Accelerator/Incubator 07-Sep-2016 Completed Startup
1. University Spin-Out 01-Jan-2015 Completed Startup
To view STENTiT’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

STENTiT Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bioresorbable vascular implants designed to reconstruct arteries and restore blood flow through natural tis
Therapeutic Devices
Eindhoven, Netherlands
13 As of 2023

Herzliya, Israel
 

Best, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

STENTiT Competitors (2)

One of STENTiT’s 2 competitors is Endospan, a Formerly VC-backed company based in Herzliya, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Endospan Formerly VC-backed Herzliya, Israel
Heart Medical Europe Private Equity-Backed Best, Netherlands
You’re viewing 2 of 2 competitors. Get the full list »

STENTiT Patents

STENTiT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025252642-A1 Fibrillated construct for extraluminal connection Pending 02-Jun-2024
EP-4801416-A1 Fibrillated mesh for a medical implant and medical implant including the same Pending 31-Oct-2023
WO-2025093685-A1 Fibrillated mesh for a medical implant and medical implant including the same Inactive 31-Oct-2023
JP-2024539473-A Method for preforming an implantable polymeric luminal support structure - patents.com Pending 24-Nov-2021
EP-4186477-A1 Method of preforming an implantable polymeric endoluminal support structure Pending 24-Nov-2021 A61F2/9522
To view STENTiT’s complete patent history, request access »

STENTiT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

STENTiT Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
European Innovation Council Accelerator/Incubator Minority
Horizon Europe Not-For-Profit Venture Capital
Brabantse Ontwikkelings Maatschappij Venture Capital Minority
Mibiton Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

STENTiT FAQs

  • When was STENTiT founded?

    STENTiT was founded in 2015.

  • Where is STENTiT headquartered?

    STENTiT is headquartered in Eindhoven, Netherlands.

  • What is the size of STENTiT?

    STENTiT has 13 total employees.

  • What industry is STENTiT in?

    STENTiT’s primary industry is Therapeutic Devices.

  • Is STENTiT a private or public company?

    STENTiT is a Private company.

  • What is STENTiT’s current revenue?

    The current revenue for STENTiT is .

  • How much funding has STENTiT raised over time?

    STENTiT has raised $1.98M.

  • Who are STENTiT’s investors?

    MedTech Innovator, European Innovation Council, Horizon Europe, Brabantse Ontwikkelings Maatschappij, and Mibiton are 5 of 11 investors who have invested in STENTiT.

  • Who are STENTiT’s competitors?

    Endospan and Heart Medical Europe are competitors of STENTiT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process